Harvard Bioscience (HBIO) EBT (2010 - 2026)
Harvard Bioscience (HBIO) reported EBT of -$3.3 million for Q1 2026, up 93.49% year-over-year from -$1.7 million in Q1 2025, and down 3.21% quarter-over-quarter from -$3.2 million in Q4 2025.
Harvard Bioscience (HBIO) EBT (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has 17 years of EBT data on file, last reported at -$3.3 million in Q1 2026.
- EBT for Q1 2026 came in at -$3.3 million, up 93.49% year-over-year; the trailing twelve-month figure through Mar 2026 was -$9.9 million (up 82.93% YoY), and the FY2025 annual result was -$57.4 million, down 391.95% from the prior year.
- EBT retreated to -$3.3 million in Q1 2026 per HBIO's latest filing, from -$3.2 million in the prior quarter.
- Over five years, EBT peaked at $3.4 million in Q2 2022 and troughed at -$50.8 million in Q1 2025.
- A 5-year average of -$4.9 million and a median of -$2.3 million in 2025 frame the typical range for EBT.
- On a YoY basis, EBT climbed as much as 641.3% in 2022 and fell as far as 10522.22% in 2022.
- A 5-year view of EBT shows it stood at -$892000.0 in 2022, then retreated by 23.65% to -$1.1 million in 2023, then jumped by 153.49% to $590000.0 in 2024, then slumped by 643.05% to -$3.2 million in 2025, then declined by 3.21% to -$3.3 million in 2026.
- Business Quant data shows HBIO's EBT at -$3.3 million in Q1 2026, -$3.2 million in Q4 2025, and -$1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 940.40 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 39.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 291.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 502.31 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 180.10 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 16.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -48.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 148.89 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -6.00 Mn |
| 10 | Harvard Bioscience | 26.17 Mn | 19.07 Mn | 12.24 Mn | -3.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.31 Mn |
| Dec 31, 2025 | -3.20 Mn |
| Sep 30, 2025 | -1.13 Mn |
| Jun 30, 2025 | -2.25 Mn |
| Mar 31, 2025 | -50.79 Mn |
| Dec 31, 2024 | 590,000.00 |
| Sep 30, 2024 | -4.49 Mn |
| Jun 30, 2024 | -3.28 Mn |
| Mar 31, 2024 | -4.48 Mn |
| Dec 31, 2023 | -1.10 Mn |
| Sep 30, 2023 | -562,000.00 |
| Jun 30, 2023 | -2.10 Mn |
| Mar 31, 2023 | 1.21 Mn |
| Dec 31, 2022 | -892,000.00 |
| Sep 30, 2022 | -4.69 Mn |
| Jun 30, 2022 | 3.42 Mn |
| Mar 31, 2022 | -7.02 Mn |
| Dec 31, 2021 | 1.13 Mn |
| Sep 30, 2021 | 45,000.00 |
| Jun 30, 2021 | -632,000.00 |